镰状细胞病患者的新型冠状病毒肺炎——来自英国一家三级医院的病例系列 - Suppr

COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.

作者信息

Chakravorty Subarna, Padmore-Payne Giselle, Ike Fester, Tshibangu Virginia, Graham Charlotte, Rees David, Stuart-Smith Sara

机构信息

Kings College Hospital NHS Trust, London, UK.

出版信息

Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.

DOI:10.3324/haematol.2020.254250

PMID:33131264

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7604654/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94e/7604654/0b62a5ec6fdf/1052691.fig1.jpg

相似文献

COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.

Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.

COVID-19 and sickle cell disease.

Haematologica. 2020 Nov 1;105(11):2501-2504. doi: 10.3324/haematol.2020.255398.

Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.

Hematology. 2020 Dec;25(1):280-282. doi: 10.1080/16078454.2020.1790842.

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.

Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23.

COVID-19 infection and sickle cell disease: a UK centre experience.

Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.

Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.

Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.

Prognosis of patients with sickle cell disease and COVID-19: a French experience.

Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.

High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.

Diabetes Res Clin Pract. 2020 Aug;166:108291. doi: 10.1016/j.diabres.2020.108291. Epub 2020 Jun 29.

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.

A hospital-based COVID-19 abortion case in the early phase of the pandemic.

Contraception. 2020 Aug;102(2):137-138. doi: 10.1016/j.contraception.2020.05.005. Epub 2020 May 19.

引用本文的文献

Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.

Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.

COVID-19 outcomes in sickle cell disease and sickle cell trait.

Best Pract Res Clin Haematol. 2022 Sep;35(3):101382. doi: 10.1016/j.beha.2022.101382. Epub 2022 Sep 7.

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.

COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes.

Front Med (Lausanne). 2021 Oct 13;8:757510. doi: 10.3389/fmed.2021.757510. eCollection 2021.

Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.

Front Med (Lausanne). 2021 Jul 22;8:679030. doi: 10.3389/fmed.2021.679030. eCollection 2021.

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease.

Blood Adv. 2021 Jul 13;5(13):2717-2724. doi: 10.1182/bloodadvances.2021004288.

Sickle cell disease and COVID-19: Susceptibility and severity.

Pediatr Blood Cancer. 2021 Aug;68(8):e29075. doi: 10.1002/pbc.29075. Epub 2021 Jun 1.

COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait.

Case Rep Crit Care. 2021 Apr 27;2021:6617362. doi: 10.1155/2021/6617362. eCollection 2021.

COVID-19 infection in patients with severe aplastic anaemia.

Br J Haematol. 2021 Jun;193(5):902-905. doi: 10.1111/bjh.17415. Epub 2021 Apr 29.

Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study.

EJHaem. 2021 Feb 10;2(2):167-174. doi: 10.1002/jha2.170. eCollection 2021 May.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.

Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.

COVID-19 and sickle cell disease.

Haematologica. 2020 Nov 1;105(11):2501-2504. doi: 10.3324/haematol.2020.255398.

Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.

Hematology. 2020 Dec;25(1):280-282. doi: 10.1080/16078454.2020.1790842.

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries.

Lancet Haematol. 2020 Jun;7(6):e430-e432. doi: 10.1016/S2352-3026(20)30122-8. Epub 2020 Apr 23.

COVID-19 infection and sickle cell disease: a UK centre experience.

Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.

Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.

Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.

Prognosis of patients with sickle cell disease and COVID-19: a French experience.

Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.

High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.

Diabetes Res Clin Pract. 2020 Aug;166:108291. doi: 10.1016/j.diabres.2020.108291. Epub 2020 Jun 29.

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.

A hospital-based COVID-19 abortion case in the early phase of the pandemic.

Contraception. 2020 Aug;102(2):137-138. doi: 10.1016/j.contraception.2020.05.005. Epub 2020 May 19.

引用本文的文献

Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.

Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.

COVID-19 outcomes in sickle cell disease and sickle cell trait.

Best Pract Res Clin Haematol. 2022 Sep;35(3):101382. doi: 10.1016/j.beha.2022.101382. Epub 2022 Sep 7.

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.

COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes.

Front Med (Lausanne). 2021 Oct 13;8:757510. doi: 10.3389/fmed.2021.757510. eCollection 2021.

Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.

Front Med (Lausanne). 2021 Jul 22;8:679030. doi: 10.3389/fmed.2021.679030. eCollection 2021.

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease.

Blood Adv. 2021 Jul 13;5(13):2717-2724. doi: 10.1182/bloodadvances.2021004288.

Sickle cell disease and COVID-19: Susceptibility and severity.

Pediatr Blood Cancer. 2021 Aug;68(8):e29075. doi: 10.1002/pbc.29075. Epub 2021 Jun 1.

COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait.

Case Rep Crit Care. 2021 Apr 27;2021:6617362. doi: 10.1155/2021/6617362. eCollection 2021.

COVID-19 infection in patients with severe aplastic anaemia.

Br J Haematol. 2021 Jun;193(5):902-905. doi: 10.1111/bjh.17415. Epub 2021 Apr 29.

Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study.

EJHaem. 2021 Feb 10;2(2):167-174. doi: 10.1002/jha2.170. eCollection 2021 May.

COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献